USNA

USANA Health Sciences Inc. - 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for the period ended June 28, 2008. USANA Health Sciences, Inc. operates as a direct selling company developing, manufacturing, and distributing nutritional and personal care products globally through a network of independent distributors ("Associates"). The company operates in one reportable segment: Direct Selling. As of the reporting date, the company had approximately 169,000 active Associates and 77,000 active Preferred Customers worldwide.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 1.5% in Q2 and 1.2% for the six months ended June 28, 2008, compared to the prior year. Growth was primarily driven by favorable foreign currency fluctuations ($4.7M in Q2; $10.2M for six months).
• Profitability Decline: Income from continuing operations decreased 11.0% in Q2 and 23.8% for the six-month period. This was due to slowing organic sales growth and increased operating costs.
• Expense Increases: Selling, General, and Administrative (SG&A) expenses rose significantly due to wage increases, higher depreciation/rent, and approximately $800,000 in non-recurring legal fees related to a terminated tender offer. Associate incentives as a percentage of sales increased to 41.8% in Q2 (from 40.2%) due to higher payout rates and promotions.
• Customer Base: The total number of active customers declined by 4.3% year-over-year, with a notable 7.7% decrease in active Associates in North America, attributed to U.S. economic uncertainty and lingering effects of negative media coverage from 2007.
• Geographic Performance: While North America sales declined, East Asia sales grew 29.5% in Q2, driven by strong performance in Hong Kong.

Guidance, Outlook, and Risks

• Management Commentary: Management expects a benefit to net sales and associate incentives in the third quarter due to the Annual International Convention. However, recent management changes and new equity grants (July 2008) are expected to reduce 2008 EPS by approximately $0.12.
• Subsequent Events: A tender offer by Unity Acquisition Corp. was terminated in July 2008. Senior management changes were announced, with David Wentz named CEO. A consolidated shareholder class action lawsuit was dismissed with prejudice in July 2008, though the plaintiff retains the right to appeal.
• Liquidity: The company maintains a $40 million credit facility with $9.8 million outstanding. Management believes current cash and operating cash flows are sufficient for foreseeable needs, though additional financing may be required for expansion.
• Risks: Key risks include the ability to attract/maintain Associates, dependence on the network marketing model, foreign currency fluctuations, regulatory scrutiny, and potential adverse publicity.

Investor Verification Checklist

• Customer Retention: Verify the trend in active Associates in North America, as this region represents the majority of sales and has shown a decline.
• Expense Run-Rate: Assess the impact of the new senior management compensation package and the $800k tender offer legal fees on future operating margins.
• Currency Exposure: Monitor foreign exchange rates, as a significant portion of the reported sales growth was attributable to currency translation rather than volume.
• Capital Expenditures: Review the completion status and cost overruns of the Salt Lake City headquarters expansion and the Sydney, Australia facility.
• Legal Status: Confirm the final status of the dismissed shareholder class action lawsuit regarding any potential appeals.